Log In Sign up
The largest database of trusted experimental protocols

Anti cd24 clone sn3

Manufactured by GeneTex
Visit Supplier

Anti-CD24 clone SN3 is a mouse monoclonal antibody that recognizes the CD24 antigen. CD24 is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein expressed on various cell types, including hematopoietic cells and some cancer cells. This antibody can be used for the identification and characterization of CD24-positive cells.

Automatically generated - may contain errors

Lab products found in correlation

Anti cd47 clone b6h12, by BioXCell (2 mentions) Anti cd40 clone g28, by BioXCell (2 mentions) Anti hpd l1 higg1, by InvivoGen (2 mentions) Anti hpd l1 higg1 n298a, by InvivoGen (2 mentions) Anti cd73 clone ad2, by BioLegend (2 mentions)

2 protocols using anti cd24 clone sn3

1

Macrophage Immune Checkpoint Therapy Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
In long-term assays to assess macrophage immune checkpoint targeting, the following macrophage-directed therapeutics were used: purified anti-CD47 clone B6H12, anti-CD40 clone G28.5 (BioXCell), anti-hPD-L1-hIgG1 (Invivogen), anti-hPD-L1-hIgG1 (N298A) (Invivogen), purified anti-CD24 clone SN3 (GeneTex), and purified anti-CD73 clone AD2 (BioLegend).
Vaccaro K., Allen J., Whitfield T.W., Maoz A., Reeves S., Velarde J., Yang D., Meglan A., Ribeiro J., Blandin J., Phan N., Bell G.W., Hata A.N, & Weiskopf K. (2024). Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. The Journal of Clinical Investigation, 134(9), e169315.
+ Open protocol
+ Expand
2

Macrophage Immune Checkpoint Targeting Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
In long-term assays to assess macrophage immune checkpoint targeting, the following macrophage-directed therapeutics were used: purified anti-CD47 clone B6H12, anti-CD40 clone G28.5 (BioXCell), anti-hPD-L1-hIgG1 (Invivogen), anti-hPD-L1-hIgG1 (N298A) (Invivogen), purified anti-CD24 clone SN3 (GeneTex), and purified anti-CD73 clone AD2 (BioLegend).
Vaccaro K., Allen J., Whitfield T.W., Maoz A., Reeves S., Velarde J., Yang D., Phan N., Bell G.W., Hata A.N, & Weiskopf K. (2023). Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. bioRxiv.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!